Skip to main content
. 2016 Mar 7;95(9):e2595. doi: 10.1097/MD.0000000000002595

FIGURE 4.

FIGURE 4

Potential oncologic effect of neoadjuvnat treatment in preoperative resectable pancreatic cancer with high MTV2.5 (MTV2.5≥4.5). Neoadjuvant chemoradiation therapy attenuated negative impact of preoperative high MTV2.5 on pancreatic cancer recurrence following radical pancreatectomy. MTV = metabolic tumor volume.